Skip to main content

eHealth, Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

EHTH$0.46+2.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Three Months Ended March 31,
20262025
Operating activities:
Net income (loss)$(4,714)$1,950
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization490471
Amortization of internally developed software2,7683,463
Stock-based compensation expense2,2583,789
Deferred income taxes(1,524)1,529
Other non-cash items346(306)
Changes in operating assets and liabilities:
Accounts receivable6,15113,421
Contract assets – commissions receivable86,43777,048
Prepaid expenses and other assets159(978)
Accounts payable(23,127)(16,034)
Accrued compensation and benefits(19,865)1,087
Accrued marketing expenses(11,453)(7,541)
Deferred revenue(2,815)(332)
Accrued expenses and other liabilities654(446)
Net cash provided by operating activities35,76577,121
Investing activities:
Capitalized internal-use software and website development costs(2,150)(3,118)
Purchases of property and equipment and other assets(155)(308)
Purchases of marketable securities(35,554)(27,362)
Proceeds from redemption and maturities of marketable securities3,50036,260
Net cash provided by (used in) investing activities(34,359)5,472
Financing activities:
Repurchase of shares to satisfy employee tax withholding obligations(160)(699)
Net cash used in financing activities(160)(699)
Effect of exchange rate changes on cash, cash equivalents and restricted cash1411
Net increase in cash, cash equivalents and restricted cash1,38781,895
Cash, cash equivalents and restricted cash at beginning of period76,81542,287
Cash, cash equivalents and restricted cash at end of period$78,202$124,182
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.